Almonty Industries shares are down about 4% in today’s session as the market revisits dilution and potential incremental selling pressure linked to its recent U.S. financing cycle. The company priced an upsized underwritten offering in December 2025 at $6.25 per share and later closed the deal including full exercise of the over-allotment option, increasing the total new-share issuance and leaving investors to reassess the post-raise share count and any residual supply overhang. (stocktitan.net)

The decline follows a period in which ALM had been driven by operational and strategic milestones, including progress at its flagship Sangdong tungsten project. Almonty announced completion of Phase 1 commissioning at Sangdong in March 2026, framing it as a return to production after decades, which helped fuel heightened expectations into 2026. With that optimism already reflected in the stock, near-term trading has become more sensitive to financing-related supply and timing questions around the ramp. (almonty.com)

Large equity raises can pressure shares even when they strengthen the balance sheet because new stock increases the float and can create a window where early buyers, participating investors, or holders coming off restrictions provide additional supply. In ALM’s case, the December 2025 upsized offering (and subsequent over-allotment exercise) expanded the number of shares sold into the market, keeping dilution in focus during bouts of volatility. (finance.yahoo.com)

Near term, traders are likely to focus on (1) evidence that Sangdong’s ramp is progressing on schedule, (2) whether any additional capital-market actions are telegraphed through shelf-prospectus flexibility, and (3) signs that financing-related selling pressure is fading. Almonty previously filed a preliminary base shelf prospectus to preserve future fundraising flexibility, which can also amplify sensitivity to perceived dilution risk during market pullbacks. (almonty.com)